Diseases We Research
Advanced Clinical Trials for Movement Disorders
Our Research Focus
At Inland Northwest Research (INWR), we are a dedicated clinical trial site specializing exclusively in movement disorders. We offer comprehensive, high-impact research opportunities for conditions like Parkinson's Disease, Huntington's Disease, and Multiple System Atrophy (MSA). Our mission is to bring patients across the Inland Northwest and beyond access to innovative investigational treatments addressing critical unmet needs.
Our Principal Investigator, Dr. Jason Aldred, leads a highly experienced, dedicated team of coordinators and nurses. This focused expertise ensures both the highest standard of patient care and the precise data collection essential to advancing research. Whether you are a potential participant seeking advanced options or a sponsor looking for a trusted, experienced partner site, you’ll find our focused expertise is our greatest strength.
Parkinson’s Disease (PD) is a complex neurodegenerative condition. While standard treatments manage motor symptoms, there remains a critical need for therapies that can slow or stop disease progression and address non-motor symptoms such as cognitive or mood changes. Our research team specializes in trials focused on these areas, offering participants access to novel investigational therapeutics designed to address these core challenges and improve quality of life.
Parkinson's Disease Research
Huntington's Disease Research
Huntington's Disease (HD) is a devastating genetic disorder for which effective disease-modifying treatments are urgently needed. Our commitment to HD research involves studies targeting the underlying genetic and molecular causes of the disease, including oligonucleotide and gene-therapy approaches. We strive to provide participants and their families with access to cutting-edge, gene-focused, and symptomatic management trials as part of the global effort to combat HD. INWR and our sister organization, Selkirk Neurology, are recognized as one of the Huntington’s Disease Society of America (HDSA) Centers of Excellence—reflecting our deep clinical expertise, research leadership, and commitment to comprehensive care for individuals and families affected by HD.
Multiple System Atrophy (MSA) is a rare, rapidly progressing condition with significant challenges and currently limited therapeutic options. INWR is dedicated to running critical, high-impact studies aimed at understanding and treating the challenging autonomic, motor, and balance issues unique to MSA. Our site is recognized for consistent reliability and high-quality data in rare disease research, and we partner closely with sponsors seeking these specialized populations.
Multiple System Atrophy (MSA) Research
Essential Tremor (ET) is one of the most common movement disorders, yet many patients do not find adequate relief from standard therapies. Our trials focus on novel pharmaceutical and device-based approaches to reduce the burden of tremor and improve daily function. We serve as a leading regional site for studies advancing ET management, giving participants access to next-generation therapies and technologies.
Essential Tremor Research
Dystonia Research
Dystonia involves sustained or intermittent muscle contractions causing abnormal, often repetitive movements. Research in Dystonia is vital to finding better ways to target the neurological pathways causing the involuntary movements and muscle rigidity. We offer studies exploring new, innovative ways to manage both focal and generalized forms of Dystonia through carefully designed clinical research aimed at advancing scientific understanding and future therapeutic development.
Other Movement Disorders
Beyond our core focuses, our dedicated team also participates in select, specialized trials for less common or complex movement disorders. This commitment ensures that individuals with diverse neurological diagnoses have the opportunity to explore advanced research options with a team of movement disorder experts.
Take the Next Step
For Research Participants
Your health journey may benefit from advanced research options not yet available through standard treatment. Our trials are designed with your safety and comfort as the priority.
For CROs and Sponsors
Partner with the dedicated, efficient movement disorder experts at INWR. We provide reliable enrollment and high-quality data, making INWR an ideal choice for your next clinical site.